nccn guidelines for hr her2 metastatic breast cancer
Published 6 years ago • 2.4K plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
1:40:05
nccn patient webinar: metastatic breast cancer
-
1:36
nccn guidelines on molecular assays for patients with breast cancer
-
6:21
nccn animation for patients: overview of endocrine therapy for metastatic breast cancer
-
5:26
nccn animation for patients: metastatic breast cancer testing explained
-
1:59
currently accepted regimens: nccn guidelines
-
3:12
treatments for hr , her2-negative metastatic breast cancer
-
2:22
her2-positive breast cancer explanation video
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
4:58
case 1: genomic testing & nccn guidelines for metastatic crc
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices
-
4:19
recommendations for her2 testing in breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
2:21
updates to the systemic treatment of metastatic breast cancer
-
1:35
dr. hurvitz on therapeutics for her2 metastatic breast cancer
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
1:47
treatment for metastatic breast cancer
-
7:44
hormonal and her2-targeted therapy in early breast cancer